Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease

Amylin, a pancreatic peptide, and amyloid-beta peptides (Aβ), a major component of Alzheimer's disease (AD) brain, share similar β-sheet secondary structures, but it is not known whether pancreatic amylin affects amyloid pathogenesis in the AD brain. Using AD mouse models, we investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, H, Wang, X, Wallack, M, Li, H, Carreras, I, Dedeoglu, A, Hur, J-Y, Zheng, H, Fine, R, Mwamburi, M, Sun, X, Kowall, N, Stern, R A, Qiu, W Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161670/
https://www.ncbi.nlm.nih.gov/pubmed/24614496
http://dx.doi.org/10.1038/mp.2014.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161670/
https://www.ncbi.nlm.nih.gov/pubmed/24614496
http://dx.doi.org/10.1038/mp.2014.17

Ejemplares similares